Literature DB >> 16513346

Development of withaferin A analogs as probes of angiogenesis.

Yasuno Yokota1, Paola Bargagna-Mohan, Padma P Ravindranath, Kyung B Kim, Royce Mohan.   

Abstract

The natural product withaferin A (WFA) is a potent angiogenesis inhibitor and it targets the ubiquitin-proteasome pathway in vascular endothelial cells. We generated a biotinylated affinity analog WFA-LC(2)B for use as a probe to study angiogenesis. WFA-LC(2)B inhibits angiogenic sprouting in vitro and it causes levels of ubiquitinated proteins to increase in tumor necrosis factor-alpha-treated human umbilical vein endothelial cells, confirming the retention of WFA's biological activity. We show that WFA-LC(2)B forms protein adducts in endothelial cells which are competed by free WFA in vivo. This WFA-LC(2)B analog will be useful to isolate the biological target of WFA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513346      PMCID: PMC3222585          DOI: 10.1016/j.bmcl.2006.02.039

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

Review 1.  Angiogenesis as a therapeutic target.

Authors:  Napoleone Ferrara; Robert S Kerbel
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study.

Authors:  R R Kulkarni; P S Patki; V P Jog; S G Gandage; B Patwardhan
Journal:  J Ethnopharmacol       Date:  1991 May-Jun       Impact factor: 4.360

3.  Immunosuppressive activity of two plant steroidal lactones withaferin A and withanolide E.

Authors:  B Shohat; I Kirson; D Lavie
Journal:  Biomedicine       Date:  1978 Jan-Feb

4.  The isolation and structural elucidation of a novel steroidal tumor inhibitor from Acnistus arborescens.

Authors:  S M Kupchan; R W Doskotch; P Bollinger; A T Mcphail; G A Sim; J A Renauld
Journal:  J Am Chem Soc       Date:  1965-12-20       Impact factor: 15.419

Review 5.  Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

Authors:  L C Mishra; B B Singh; S Dagenais
Journal:  Altern Med Rev       Date:  2000-08

6.  Antitumor activity of withaferin A (NSC-101088).

Authors:  B Shohat; S Gitter; A Abraham; D Lavie
Journal:  Cancer Chemother Rep       Date:  1967-09

7.  Novel cytotoxic and antitumor agents. IV. Withaferin A: relation of its structure to the in vitro cytotoxic effects on P388 cells.

Authors:  J Fuska; A Fusková; J P Rosazza; A W Nicholas
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

8.  Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves.

Authors:  Bolleddula Jayaprakasam; Yanjun Zhang; Navindra P Seeram; Muraleedharan G Nair
Journal:  Life Sci       Date:  2003-11-21       Impact factor: 5.037

9.  Anti-granuloma activity of Iraqi Withania somnifera.

Authors:  M K al-Hindawi; S H al-Khafaji; M H Abdul-Nabi
Journal:  J Ethnopharmacol       Date:  1992-09       Impact factor: 4.360

Review 10.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

View more
  19 in total

Review 1.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

2.  Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.

Authors:  Dong Wook Lim; Jae Goo Kim; Eun Yeong Lim; Yun Tai Kim
Journal:  Inflammopharmacology       Date:  2017-08-28       Impact factor: 4.473

3.  Chemistry of withaferin-A: chemo, regio, and stereoselective synthesis of novel spiro-pyrrolizidino-oxindole adducts of withaferin-A via one-pot three-component [3+2] azomethine ylide cycloaddition and their cytotoxicity evaluation.

Authors:  Yogesh P Bharitkar; Satish Kanhar; Neradibilli Suneel; Susanta Kumar Mondal; Abhijit Hazra; Nirup B Mondal
Journal:  Mol Divers       Date:  2015-03-08       Impact factor: 2.943

4.  Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin.

Authors:  Paola Bargagna-Mohan; Riya R Paranthan; Adel Hamza; Chang-Guo Zhan; Do-Min Lee; Kyung Bo Kim; Daniel L Lau; Cidambi Srinivasan; Keiko Nakayama; Keiichi I Nakayama; Harald Herrmann; Royce Mohan
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

5.  Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells.

Authors:  Mancang Gu; Yanke Yu; G M Kamal B Gunaherath; A A Leslie Gunatilaka; Dapeng Li; Duxin Sun
Journal:  Invest New Drugs       Date:  2013-07-26       Impact factor: 3.850

6.  A novel HSP90 modulator with selective activity against thyroid cancers in vitro.

Authors:  Abbas Samadi; Peter Loo; Rithwi Mukerji; Gemma O'Donnell; Xiaqin Tong; Barbara N Timmermann; Mark S Cohen
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

7.  Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.

Authors:  Guy Lahat; Quan-Sheng Zhu; Kai-Lieh Huang; Suizhao Wang; Svetlana Bolshakov; Jeffery Liu; Keila Torres; Robert R Langley; Alexander J Lazar; Mien Chie Hung; Dina Lev
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

8.  Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway.

Authors:  Abbas K Samadi; Joseph Bazzill; Xuan Zhang; Rob Gallagher; Hauping Zhang; Rao Gollapudi; Kelly Kindscher; Barbara Timmermann; Mark S Cohen
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

9.  Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

Authors:  Yanke Yu; Adel Hamza; Tao Zhang; Mancang Gu; Peng Zou; Bryan Newman; Yanyan Li; A A Leslie Gunatilaka; Chang-Guo Zhan; Duxin Sun
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

10.  Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays.

Authors:  David G Belair; Michael P Schwartz; Thomas Knudsen; William L Murphy
Journal:  Acta Biomater       Date:  2016-05-13       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.